XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information
 6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company has two operating segments, which constitute the Company’s two reportable segments and the Company’s CEO is the Chief Operating Decision Maker (“CODM”), as defined in ASC Topic 280 - Segment Reporting. Our performance is assessed and resources allocated by the CODM based on the following two reportable segments:

•Prescription Pharmaceuticals
•Consumer Health

The Company’s Prescription Pharmaceuticals segment principally consists of generic and branded prescription pharmaceuticals products which span a broad range of indications as well as a variety of dosage forms including: sterile ophthalmics, injectables and inhalants, and non-sterile oral liquids, topicals and nasal sprays. The Company’s Consumer Health segment principally consists of animal health and over-the-counter (“OTC”) products, both branded and private label. OTC products include, but are not limited to, a suite of products for the treatment of dry eye sold under the TheraTears® brand name.

Financial information about the Company’s reportable segments is based upon internal financial reports that aggregate certain operating information. The Company’s CODM oversees operational assessments and resource allocations based upon the results of the Company’s reportable segments, which have available and discrete financial information.
Selected financial information by reportable segment is presented below (in thousands):

Three Months Ended
June 30,		Six Months Ended
June 30,
 2020201920202019
Revenues, net:  
Prescription Pharmaceuticals$104,424  $158,379  $283,668  $306,394  
Consumer Health15,886  19,678  41,335  37,534  
Total revenues, net120,310  178,057  325,003  343,928  
Gross Profit:  
Prescription Pharmaceuticals21,247  59,785  98,407  105,228  
Consumer Health9,805  8,199  27,189  16,269  
Total gross profit31,052  67,984  125,596  121,497  
Operating expenses86,930  155,350  428,392  274,346  
OPERATING (LOSS)(55,878) (87,366) (302,796) (152,849) 
Other expenses, net(38,548) (22,751) (71,802) (38,029) 
(Loss) before income taxes$(94,426) $(110,117) $(374,598) $(190,878) 

The Company manages its business segments to the gross profit level and manages its operating and other costs on a company-wide basis. Inter-segment activity at the gross profit level is minimal. The Company does not have discrete assets by segment, as certain manufacturing and warehouse facilities support more than one segment, and therefore does not report assets by segment. Financial information including revenues and gross profit by product or product line is not provided, as to do so would be impracticable.

The following table sets forth the Company’s net revenues by geographic region for the three and six month periods ended June 30, 2020 and 2019. The Domestic region represents sales within the United States of America and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):

Three Months Ended
June 30, 2020		Three Months Ended
June 30, 2019		Six Months Ended
June 30, 2020		Six Months Ended
June 30, 2019
RegionAmount% of Total RevenuesAmount% of Total RevenuesAmount% of Total RevenuesAmount% of Total Revenues
Domestic$119,212  99.1%$174,109  97.8%$321,045  98.8%$338,243  98.3%
Foreign1,098  0.9%3,948  2.2%3,958  1.2%5,685  1.7%
Total Revenues$120,310  100.0%$178,057  100.0%$325,003  100.0%$343,928  100.0%